← board
OABI
distress 5/10 · elevated risk$2.08-2%today-24% from 52w high
Revenue
$14M
Liquidity
$29M
Runway
1.1 yrs
Shares 1y
+18%
Price & events
+0.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
-1.6%
1D
+1.8%
1W
-10.9%
1M
+33.1%
3M
+5.9%
6M
-3.4%
1Y
-56.1%
2Y
—
5Y
-78.7%
All
Overview
- Market Cap
- $300.96M
- Volume
- 16.82K
- 52 Week Range
- $1.36 – $2.72
- Total Shares
- 144.97M
- Float Shares
- 113.85M
- Short %
- 3.60%
- % Held by Insiders
- 15.33%
- % Held by Institutions
- 50.97%
- RVOL
- 0.03x
- Beta
- 1.17
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-06earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- 2025-08-07RBC CapitalOutperform
- 2025-05-12BenchmarkBuy
- 2025-03-27RBC CapitalOutperform
- 2025-03-20BenchmarkBuy
- 2025-03-19HC Wainwright & Co.Buy
- 2024-11-14BenchmarkBuy
Competitors
- none identified
Recent news
- 2026-07-22Enterprise value to EBITDA forward of OmniAb, Inc. – NASDAQ:OABI - TradingView
- 2026-07-16OmniAb Q1 2026 Earnings: EPS Surprises Positively Despite Pre-Revenue Stage - Special Dividend Alert - dars.gov.et
- 2026-07-16OmniAb to Report Second Quarter 2026 Financial Results on August 6 - Business Wire
- 2026-07-13OmniAb Appoints Amechi Nwachuku as Chief Operating Officer Effective July 13, 2026 - geneonline.com
- 2026-07-13OmniAb, Inc. Appoints Amechi Nwachuku as Chief Operating Officer – Leadership Update July 2026 - Minichart
- 2026-07-13Omniab, Inc. Appoints Amechi Nwachuku as Executive Vice President and Chief Operating Officer, Effective July 13, 2026 - marketscreener.com
- 2026-07-13OmniAb Taps Amechi Nwachuku as Executive Vice President & Chief Operating Officer - Contract Pharma
- 2026-07-13OmniAb stock rises after naming new chief operating officer By Investing.com - Investing.com Nigeria
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.